Header Logo

SAIRA KHADERI

TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address6620 MAIN
Houston, TX 77030
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. Saira Khaderi has research interest in liver transplant outcomes - specifically in patients transplanted with hepatitis C and hepatocellular carcinoma. She is also involved in Project ECHO ((Extension for Community Healthcare Outcomes) - a telementoring program whose aim is to improve medical resources in rural and under served communities in Texas.

    Since she was an intern at the Cleveland Clinic Foundation, Dr. Saira Khaderi has developed a strong interest in hepatology and liver transplantation. During her residency, she was involved in research related to complications of portal hypertension, and in 2006 she was honored with the American Association for the Study of Liver Diseases Travel Scholar Award – an award given to accomplished trainees with potential for a career in academic medicine. After completing her residency, she returned to Houston and continued working in transplant medicine at Methodist Hospital, where she was an active member of the liver and kidney transplant programs.

    Dr. Khaderi began her Transplant Hepatology Fellowship at Baylor College of Medicine in the summer of 2012. Her research regarding outcomes of patients transplanted with portopulmonary hypertension has been presented at several major conferences, including the 48th Annual Meeting of the European Association for the Study of the Liver (EASL) in Amsterdam and in the Digestive Disease Week (DDW) in Orlando. Her current research interests include hepatitis C, complications of portal hypertension, and liver transplant outcomes.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hassan MM, Li D, Han Y, Byun J, Hatia RI, Long E, Choi J, Kelley RK, Cleary SP, Lok AS, Bracci P, Permuth JB, Bucur R, Yuan JM, Singal AG, Jalal PK, Ghobrial RM, Santella RM, Kono Y, Shah DP, Nguyen MH, Liu G, Parikh ND, Kim R, Wu HC, El-Serag H, Chang P, Li Y, Chun YS, Lee SS, Gu J, Hawk E, Sun R, Huff C, Rashid A, Amin HM, Beretta L, Wolff RA, Antwi SO, Patt Y, Hwang LY, Klein AP, Zhang K, Schmidt MA, White DL, Goss JA, Khaderi SA, Marrero JA, Cigarroa FG, Shah PK, Kaseb AO, Roberts LR, Amos CI. Genome-wide association study identifies high-impact susceptibility loci for hepatocellular carcinoma in North America. Hepatology. 2024 Feb 20. PMID: 38381705.
      Citations:    Fields:    
    2. El-Serag H, Kanwal F, Ning J, Powell H, Khaderi S, Singal AG, Asrani S, Marrero JA, Amos CI, Thrift AP, Luster M, Alsarraj A, Olivares L, Skapura D, Deng J, Salem E, Najjar O, Yu X, Duong H, Scheurer ME, Ballantyne CM, Kaochar S. Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis. Gut. 2024 Feb 16. PMID: 38365278.
      Citations:    Fields:    
    3. El-Serag HB, Akhdar G, Thrift AP, Luster M, Khaderi S, Alsarraj A, Duong H, Kanwal F. Bioimpedance analysis predicts the etiology of cirrhosis in a prospective cohort study. Hepatol Commun. 2023 10 01; 7(10). PMID: 37695087; PMCID: PMC10497244.
      Citations:    Fields:    Translation:Humans
    4. Kanwal F, Khaderi S, Singal AG, Marrero JA, Asrani SK, Amos CI, Thrift AP, Kramer JR, Yu X, Cao Y, Luster M, Al-Sarraj A, Ning J, El-Serag HB. Risk Stratification Model for Hepatocellular Cancer in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2023 12; 21(13):3296-3304.e3. PMID: 37390101; PMCID: PMC10661677.
      Citations:    Fields:    Translation:Humans
    5. Thrift AP, Kanwal F, Liu Y, Khaderi S, Singal AG, Marrero JA, Loo N, Asrani SK, Luster M, Al-Sarraj A, Ning J, Tsavachidis S, Gu X, Amos CI, El-Serag HB. Risk stratification for hepatocellular cancer among patients with cirrhosis using a hepatic fat polygenic risk score. PLoS One. 2023; 18(2):e0282309. PMID: 36854015; PMCID: PMC9974109.
      Citations: 1     Fields:    Translation:Humans
    6. Kanwal F, Khaderi S, Singal AG, Marrero JA, Loo N, Asrani SK, Amos CI, Thrift AP, Gu X, Luster M, Al-Sarraj A, Ning J, El-Serag HB. Risk factors for HCC in contemporary cohorts of patients with cirrhosis. Hepatology. 2023 03 01; 77(3):997-1005. PMID: 35229329; PMCID: PMC9433461.
      Citations:    Fields:    
    7. Khaderi S, Kanwal F. Changing epidemiology of hepatocellular cancer in the United States: Winning the battle but it is not over yet. Hepatology. 2022 09; 76(3):546-548. PMID: 35388520.
      Citations:    Fields:    
    8. Shaikh A, Goli K, Rich NE, Benhammou JN, Khaderi S, Hernaez R, Agopian VG, Vierling JM, Kim D, Ahmed A, Goss JA, Rana A, Kanwal F, Cholankeril G. Early Impact of MMaT-3 Policy on Liver Transplant Waitlist Outcomes for Hepatocellular Carcinoma. Transplant Direct. 2022 May; 8(5):e1313. PMID: 35434283; PMCID: PMC9005245.
      Citations:    
    9. Volk ML, Clarke C, Asrani SK, Khaderi S, Bansal MB, Tapper EB, Ho C, Chung RT, Lake J, Lim N, Fortune BE, Kim R, Dronamraju D, Kanwal F. Cirrhosis Quality Collaborative. Clin Gastroenterol Hepatol. 2022 05; 20(5):970-972. PMID: 35123089.
      Citations:    Fields:    Translation:Humans
    10. Shapiro JM, Himes R, Khaderi S, Economides J, El-Serag HB. A multidisciplinary approach to improving transition readiness in pediatric liver transplant recipients. Pediatr Transplant. 2021 03; 25(2):e13839. PMID: 32997866.
      Citations:    Fields:    Translation:Humans
    11. Ismail MS, Hassan M, Khaderi SA, Yousry WA, Kamal El-Din MM, Bahaa El-Din MM, El Sayed OA, Kaseb AO, Goss JA, Kanwal F, Jalal PK. Clinical efficacy of direct-acting antiviral therapy for recurrent hepatitis C virus infection after liver transplantation in patients with hepatocellular carcinoma. World J Hepatol. 2020 Sep 27; 12(9):628-640. PMID: 33033569; PMCID: PMC7522560.
      Citations: 1     
    12. El-Serag HB, Kanwal F, Feng Z, Marrero JA, Khaderi S, Singal AG, Texas Hepatocellular Carcinoma Consortium. Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings From the Texas Hepatocellular Carcinoma Consortium Cohort. Gastroenterology. 2020 07; 159(1):376-377. PMID: 32234536; PMCID: PMC8375364.
      Citations: 8     Fields:    Translation:Humans
    13. Feng Z, Marrero JA, Khaderi S, Singal AG, Kanwal F, Loo N, Beretta L, Ning J, El-Serag HB. Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study. Am J Gastroenterol. 2019 03; 114(3):530-532. PMID: 30699099.
      Citations: 11     Fields:    Translation:Humans
    14. Khaderi SA. Introduction: Alcohol and Alcoholism. Clin Liver Dis. 2019 02; 23(1):1-10. PMID: 30454824.
      Citations: 7     Fields:    Translation:Humans
    15. Khaderi S, Sussman N, Kanwal F. Project ECHO: The Specialist Will See You Now. Hepatology. 2018 12; 68(6):2066-2068. PMID: 30033576.
      Citations: 1     Fields:    Translation:Humans
    16. Frenette CT, Morelli G, Shiffman ML, Frederick RT, Rubin RA, Fallon MB, Cheng JT, Cave M, Khaderi SA, Massoud O, Pyrsopoulos N, Park JS, Robinson JM, Yamashita M, Spada AP, Chan JL, Hagerty DT. Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With Placebo. Clin Gastroenterol Hepatol. 2019 03; 17(4):774-783.e4. PMID: 29913280.
      Citations: 24     Fields:    Translation:Humans
    17. Mindikoglu AL, Opekun AR, Mitch WE, Magder LS, Christenson RH, Dowling TC, Weir MR, Seliger SL, Howell CD, Raufman JP, Rana A, Goss JA, Khaderi SA, Vierling JM. Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis. Dig Dis Sci. 2018 03; 63(3):665-675. PMID: 29392554; PMCID: PMC5994910.
      Citations: 9     Fields:    Translation:Humans
    18. Hassan MM, Botrus G, Abdel-Wahab R, Wolff RA, Li D, Tweardy D, Phan AT, Hawk E, Javle M, Lee JS, Torres HA, Rashid A, Lenzi R, Hassabo HM, Abaza Y, Shalaby AS, Lacin S, Morris J, Patt YZ, Amos CI, Khaderi SA, Goss JA, Jalal PK, Kaseb AO. Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2017 Nov; 15(11):1791-1799. PMID: 28579181; PMCID: PMC5901750.
      Citations: 33     Fields:    Translation:Humans
    19. Khaderi SA, Hollinger FB. Is the Risk of Death Enhanced in Immunosuppressed Hepatitis B?Virus-infected Patients Who Develop Acute Liver Failure? Clin Gastroenterol Hepatol. 2017 01; 15(1):123-126. PMID: 27693523.
      Citations:    Fields:    Translation:HumansCells
    20. Thornton K, Deming P, Manch RA, Moore A, Kohli A, Gish R, Sussman NL, Khaderi S, Scott J, Mera J, Box T, Qualls C, Sedillo M, Arora S. Is response guided therapy dead? Low cure rates in patients with detectable hepatitis C virus at week 4 of treatment. Hepatol Int. 2016 Jul; 10(4):624-31. PMID: 27098355.
      Citations: 8     Fields:    Translation:HumansCells
    21. Carrion AF, Khaderi SA, Sussman NL. Model for end-stage liver disease limbo, model for end-stage liver disease purgatory, and the dilemma of treating hepatitis C in patients awaiting liver transplantation. Liver Transpl. 2016 Mar; 22(3):279-80. PMID: 26663608.
      Citations: 11     Fields:    Translation:HumansCells
    22. Khaderi SA, Sussman NL. Screening for malignancy in primary sclerosing cholangitis (PSC). Curr Gastroenterol Rep. 2015 Apr; 17(4):17. PMID: 25786901.
      Citations: 13     Fields:    Translation:Humans
    23. Rana A, Pallister ZS, Guiteau JJ, Cotton RT, Halazun K, Nalty CC, Khaderi SA, O'Mahony CA, Goss JA. Survival Outcomes Following Pediatric Liver Transplantation (Pedi-SOFT) Score: A Novel Predictive Index. Am J Transplant. 2015 Jul; 15(7):1855-63. PMID: 25689873.
      Citations: 4     Fields:    Translation:Humans
    24. Khaderi S, Guiteau J, Cotton RT, O'Mahony C, Rana A, Goss JA. Role of liver transplantation in the management of hepatoblastoma in the pediatric population. World J Transplant. 2014 Dec 24; 4(4):294-8. PMID: 25540737; PMCID: PMC4274598.
      Citations: 10     
    25. Khaderi S, Shepherd R, Goss JA, Leung DH. Hepatitis C in the pediatric population: transmission, natural history, treatment and liver transplantation. World J Gastroenterol. 2014 Aug 28; 20(32):11281-6. PMID: 25170212; PMCID: PMC4145766.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    26. Khaderi S, Khan R, Safdar Z, Stribling R, Vierling JM, Goss JA, Sussman NL. Long-term follow-up of portopulmonary hypertension patients after liver transplantation. Liver Transpl. 2014 Jun; 20(6):724-7. PMID: 24648168.
      Citations: 12     Fields:    Translation:Humans
    27. Khaderi S, Barnes D. Preventing a first episode of esophageal variceal hemorrhage. Cleve Clin J Med. 2008 Mar; 75(3):235-44. PMID: 18383932.
      Citations: 4     Fields:    Translation:Humans
    KHADERI's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (131)
    Explore
    _
    Co-Authors (42)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _